National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate Cancer. Read more about National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate Cancer.
Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202. Read more about Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-Term Update of NRG Oncology RTOG 9202.
Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial. Read more about Feasibility of Patient Reporting of Symptomatic Adverse Events via the Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE) in a Chemoradiotherapy Cooperative Group Multicenter Clinical Trial.
Palliative Care Didactic Course for Radiation Oncology Residents. Read more about Palliative Care Didactic Course for Radiation Oncology Residents.
Pan-Cancer Analysis of Genomic Sequencing Among the Elderly. Read more about Pan-Cancer Analysis of Genomic Sequencing Among the Elderly.
Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (≥5 cm) Non-Small Cell Lung Cancer: A Multi-institutional Analysis. Read more about Influence of Fractionation Scheme and Tumor Location on Toxicities After Stereotactic Body Radiation Therapy for Large (≥5 cm) Non-Small Cell Lung Cancer: A Multi-institutional Analysis.
A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012. Read more about A Randomized Phase 2 Trial of Prophylactic Manuka Honey for the Reduction of Chemoradiation Therapy-Induced Esophagitis During the Treatment of Lung Cancer: Results of NRG Oncology RTOG 1012.
Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation. Read more about Patterns of Relapse in High-Risk Neuroblastoma Patients Treated With and Without Total Body Irradiation.
